Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-23-013819

Chief Executive Officer bought 4,000 shares at $2.50 ($10,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Vitoc Vlad · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-28 Purchase : show line 1 in the form 10b5-1 +4,000 $2.50 $10,000 809,121 D
Open-market purchases · 4,000 sh · avg $2.50 · $10,000
Loading xslF345X04/form4.xml…